BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim KC, Yun J, Son DJ, Kim JY, Jung JK, Choi JS, Kim YR, Song JK, Kim SY, Kang SK, Shin DH, Roh YS, Han SB, Hong JT. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1. Theranostics 2018;8:4409-28. [PMID: 30214629 DOI: 10.7150/thno.26467] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ismail H, Helby J, Hölmich LR, Chakera AH, Bastholt L, Klyver H, Sjøgren P, Schmidt H, Schöllhammer L, Johansen JS, Nordestgaard BG, Bojesen SE. Measured and genetically predicted plasma YKL-40 levels and melanoma mortality. Eur J Cancer 2019;121:74-84. [PMID: 31563729 DOI: 10.1016/j.ejca.2019.08.025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Dichev V, Mehterov NH, Kazakova MH, Karalilova RV, Batalov AZ, Sarafian VS. Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis. Mod Rheumatol 2021;31:1010-8. [PMID: 33274678 DOI: 10.1080/14397595.2020.1859726] [Reference Citation Analysis]
3 Chen Q, Zhang H, Zhang J, Shen L, Yang J, Wang Y, Ma J, Zhuan B. miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3. Onco Targets Ther 2021;14:3687-700. [PMID: 34140779 DOI: 10.2147/OTT.S288788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 Like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:201. [PMID: 32929074 DOI: 10.1038/s41392-020-00303-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
5 Ham HJ, Lee YS, Yun J, Son DJ, Lee HP, Han SB, Hong JT. K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway. J Neuroinflammation 2020;17:350. [PMID: 33222690 DOI: 10.1186/s12974-020-02022-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Im JH, Yeo IJ, Park PH, Choi DY, Han SB, Yun J, Hong JT. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of Neuroinflammation by STAT6-dependent M2 microglial inactivation in Chitinase-3-like 1 knockout mice. Exp Neurol 2020;323:113082. [PMID: 31669069 DOI: 10.1016/j.expneurol.2019.113082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Lee DH, Han JH, Lee YS, Jung YS, Roh YS, Yun JS, Han SB, Hong JT. Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis. Metabolism 2019;95:46-56. [PMID: 30935969 DOI: 10.1016/j.metabol.2019.03.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yu JE, Yeo IJ, Son DJ, Yun J, Han SB, Hong JT. Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization. Mol Oncol 2021. [PMID: 34861103 DOI: 10.1002/1878-0261.13152] [Reference Citation Analysis]
9 Chen W, Jiang X, Yang Q. Glycoside hydrolase family 18 chitinases: The known and the unknown. Biotechnology Advances 2020;43:107553. [DOI: 10.1016/j.biotechadv.2020.107553] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
10 Kumar A, Zhang KYJ. Human Chitinases: Structure, Function, and Inhibitor Discovery. Adv Exp Med Biol 2019;1142:221-51. [PMID: 31102249 DOI: 10.1007/978-981-13-7318-3_11] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 2020;131:110680. [PMID: 32861071 DOI: 10.1016/j.biopha.2020.110680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang PS, Yu MH, Hou YC, Chang CP, Lin SC, Kuo IY, Su PC, Cheng HC, Su WC, Shan YS, Wang YC. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Theranostics 2022;12:340-61. [PMID: 34987649 DOI: 10.7150/thno.65522] [Reference Citation Analysis]
13 Kang K, Kim K, Lee SR, Kim Y, Lee JE, Lee YS, Lim JH, Lim CS, Kim YJ, Baek SI, Song DH, Hong JT, Kim DY. Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries. Int J Mol Sci 2020;21:E6354. [PMID: 32883029 DOI: 10.3390/ijms21176354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen L, Han S, Li Y, Zheng Y, Zhang Q. SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer. Exp Cell Res 2022;:113194. [PMID: 35523305 DOI: 10.1016/j.yexcr.2022.113194] [Reference Citation Analysis]
15 Chen Q, Xie X. Association of Exosomal miR-210 with Signaling Pathways Implicated in Lung Cancer. Genes (Basel) 2021;12:1248. [PMID: 34440422 DOI: 10.3390/genes12081248] [Reference Citation Analysis]
16 Liu S, Qiu J, He W, Geng C, He G, Liu C, Cai D, Liu X, Tian B, Pan H. TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis. MedComm (2020) 2020;1:386-99. [PMID: 34766130 DOI: 10.1002/mco2.38] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lee YS, Yu JE, Kim KC, Lee DH, Son DJ, Lee HP, Jung JK, Kim ND, Ham YW, Yun J, Han SB, Hong JT. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals. Mol Oncol 2021. [PMID: 34758182 DOI: 10.1002/1878-0261.13138] [Reference Citation Analysis]
18 Xing J, Wang Z, Xu H, Liu C, Wei Z, Zhao L, Ren L. Pak2 inhibition promotes resveratrol-mediated glioblastoma A172 cell apoptosis via modulating the AMPK-YAP signaling pathway. J Cell Physiol 2020;235:6563-73. [PMID: 32017068 DOI: 10.1002/jcp.29515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets. Int J Biol Markers 2022;:3936155221084056. [PMID: 35254116 DOI: 10.1177/03936155221084056] [Reference Citation Analysis]
20 Yeo IJ, Lee CK, Han SB, Yun J, Hong JT. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacol Ther 2019;203:107394. [PMID: 31356910 DOI: 10.1016/j.pharmthera.2019.107394] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]